Welcome to our dedicated page for Envista Holdings Corporation news (Ticker: NVST), a resource for investors and traders seeking the latest updates and insights on Envista Holdings Corporation stock.
Envista Holdings Corporation (NYSE: NVST) is a leading global dental products company committed to empowering dental professionals worldwide. Headquartered in Brea, California, Envista develops, manufactures, and markets an extensive portfolio of dental consumables, equipment, and services. The company operates through two primary segments: Specialty Products & Technologies and Equipment & Consumables.
The Specialty Products & Technologies segment focuses on dental implant systems, regenerative solutions, dental prosthetics, orthodontic systems, and lab products. This segment is dedicated to advancing the capabilities of dental professionals through innovative products and technologies.
The Equipment & Consumables segment offers a broad range of dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization and magnification systems, supporting the diagnostic, treatment, and prevention needs of dental conditions.
Envista has a strong commitment to continuous improvement, action-oriented innovation, and a deep respect for dental professionals. Its comprehensive product portfolio covers an estimated 90% of dentists’ clinical needs, ensuring a holistic approach to dental care.
Recent achievements include the launch of the DEXIS digital ecosystem, an AI-powered platform designed to streamline implant dentistry workflows. This interconnected system combines cutting-edge CBCT, intraoral scanning, diagnostics, and treatment planning, empowering clinicians to manage implant cases efficiently.
Envista continues to innovate with products like the ORTHOPANTOMOGRAPH™ OP 3D™ LX, which enhances 3D diagnostic capabilities, and the IS ScanFlow software, which integrates AI-driven tools to maximize productivity in dental practices.
Financially, Envista reported sales of $623.6 million for the first quarter of 2024, with core sales growth and ongoing investments aimed at accelerating growth and profitability. The company has a proven track record of resilience and strategic differentiation, particularly through the challenges posed by the global pandemic and other economic factors.
Envista's philanthropic arm, the Envista Smile Project, exemplifies its commitment to social responsibility. The project has donated millions to improve access to oral health for underserved communities, partnering with institutions like the University of Southern California to enhance dental care for vulnerable populations.
Envista's significant market positions in attractive dental segments, coupled with its continuous improvement culture and innovation-driven approach, make it a pivotal player in the dental industry. For more information, visit the official website at www.envistaco.com.
Envista Holdings Corporation (NYSE: NVST) reported a 3.9% increase in sales for Q3 2022, totaling $631.1 million. Core sales growth stood at 4.9% compared to Q3 2021. Net income reached $49.6 million, translating to $0.28 per diluted share, while adjusted net income improved to $82.5 million or $0.47 per diluted share. Adjusted EBITDA rose to $127.6 million, reflecting a 20.2% margin. Despite economic challenges, the company maintains its guidance for mid-single-digit core sales growth and a 20% adjusted EBITDA margin for 2022.
Envista Holdings Corporation (NYSE: NVST) announced its participation in the Jefferies London Healthcare Conference on November 17, 2022, from 9:45 - 10:15 AM GMT. Investors can access audio recordings of the event via the Investor Relations section on Envista's website. Envista, a leading global dental products company with over 30 renowned brands, focuses on enhancing patient care through innovative solutions and services.
Envista Holdings Corporation (NYSE: NVST) will announce its third quarter 2022 financial results on November 3, 2022. A conference call is scheduled for the same day at 2:00 PM PT, expected to last approximately one hour. The results and related materials will be available on the company's website prior to the call. Envista is a global leader in dental products, encompassing more than 30 trusted brands and providing a comprehensive range of dental solutions.
Envista Holdings Corporation (NYSE: NVST) will join the Piper Sandler MedTech and Diagnostics California Bus Tour on August 24, 2022, from 10:00 to 10:50 AM PT in Laguna Niguel, California. This in-person event will not be webstreamed. Envista, a leading global dental products company with over 30 trusted brands, focuses on improving patient care through its comprehensive portfolio, including dental implants, orthodontics, and digital imaging technologies. The company aims to meet the diverse clinical needs of dental professionals worldwide.
Envista Holdings Corporation (NYSE: NVST) reported a 1.3% sales increase to $645.8 million for Q2 2022, with core sales growth of 4%. Net income reached $44.5 million ($0.25 per diluted share), while adjusted net income was $86 million ($0.48 per diluted share), up from $0.46 in Q2 2021. Adjusted EBITDA rose to $126.9 million. CEO Amir Aghdaei noted ongoing supply chain challenges and geopolitical uncertainties but highlighted success in acquisitions, namely Carestream Dental's IOS business and Osteogenics' solutions. However, the company adjusted its 2022 guidance, anticipating mid-single digit core sales growth.
Envista Holdings announced an extension of its partnership with dentalcorp, Canada's largest dental service organization. This collaboration aims to enhance implant treatment capabilities across over 500 dentalcorp practices. Nobel Biocare, a subsidiary of Envista, will provide comprehensive support and training to more than 1,500 dentists within dentalcorp's network. This partnership emphasizes Envista's commitment to supporting dental professionals and improving patient care, focusing on digital and personalized solutions in the dental sector.
Envista Holdings Corporation (NYSE: NVST) will announce its financial results for Q2 2022 on August 3, 2022. A conference call is scheduled for 2:00 PM PT that same day, accessible via phone or webcast. Investors can expect a detailed discussion of the results, which will be accompanied by a slide presentation available on Envista's website. This call aims to provide insights into the company's performance, reflecting its commitment to enhancing customer care through a comprehensive range of dental solutions.
Envista Holdings Corporation (NYSE: NVST) will participate in the Stifel 2022 Jaws & Paws Conference on June 1, 2022, from 9:45 to 10:15 AM EST in New York City. Investors can access live streams or recordings via the company's Investor Relations website. Envista is a leading global dental products company, comprising over 30 trusted brands that offer dental consumables, solutions, and technology. The company focuses on improving patient care and is well-positioned in attractive segments of the dental industry.
Envista Holdings Corporation (NYSE: NVST) announced on May 17, 2022, that it has entered into a definitive agreement to acquire Osteogenics Biomedical Inc, Allotech LLC, and OBI Biologics, collectively referred to as Osteogenics. The deal aims to enhance Envista's regenerative solutions for dental professionals and is expected to close in Q3, pending regulatory approvals. Osteogenics is recognized for innovative bone grafting products, primarily marketed under the Cytoplast brand. The acquisition aligns with Envista's strategy to innovate in oral care and strengthen its market position.
FAQ
What is the current stock price of Envista Holdings Corporation (NVST)?
What is the market cap of Envista Holdings Corporation (NVST)?
What does Envista Holdings Corporation do?
What are the main segments of Envista's business?
What recent achievements has Envista made?
How did Envista perform financially in the first quarter of 2024?
What is the Envista Smile Project?
Who is the new CEO of Envista Holdings Corporation?
How does Envista support dental professionals?
What is the DEXIS digital ecosystem?
What is the Envista Business System (EBS)?
Where can I find more information about Envista Holdings Corporation?
